Sex-dependent associations of leptin with metabolic syndrome-related variables: The stanislas study

Obesity

Volumn 18, Issue 1, 2010, Pages 196-201

  Samara, Anastasia ^a   Herbeth, Bernard ^a   Aubert, Roberte ^b   Berrahmoune, Hind ^a   Fumeron, Frédéric ^b,c   Siest, Gérard ^a   Visvikis Siest, Sophie ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEPTIN; LIPID; URIC ACID;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPEDANCE; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PHYSIOLOGY; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPTIN; LIPIDS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; URIC ACID; WAIST CIRCUMFERENCE;

EID: 73949110685     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.156     Document Type: Article

References (24)

1. Després J P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
2. Rector RS, Thyfault J P, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008;14: 185-192.
3. Franks PW, Brage S, Luan J et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res 2005;13:1476-1484.
4. Abdullah SM, Khera A, Leonard D et al. Sex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 2007;195:404-410.
5. Engström G, Stavenow L, Hedblad B et al. Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol 2003;23:2247-2251. (Pubitemid 37532328)
6. Onat A, Uyarel H, Hergenç G et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006;19:1055-1062.
7. Siest G, Visvikis S, Herbeth B et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 1998;36:35-42.
8. Lecomte E, Herbeth B, Nicaud V et al. Segregation analysis of fat mass and fat-free mass with age-and sex-dependent effects: the Stanislas Family Study. Genet Epidemiol 1997;14:51-62.
9. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 1988;47:7-14.
10. Belsley DA, Kuh E, Welsch RE. Regression Diagnostics. John Wiley & Sons: New York, 1980.
11. Schreiner PJ, Terry JG, Evans GW et al. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1996;144:335-345.
12. Valtueña S, Numeroso F, Ardigò D et al. Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels. Eur J Endocrinol 2005;153:283-290.
13. Barzilai N, Wang J, Massilon D et al. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997;100:3105-3110.
14. Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM. Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Endocrinology 2006;147:1480-1487.
15. Silver DL, Jiang XC, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 1999;274:4140-4146.
16. Hallikainen M, Kolehmainen M, Schwab U et al. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome. Clin Chim Acta 2007;383:126-132.
17. Cohen P, Friedman JM. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr 2004;134:2455S-2463S.
18. Rebuffé-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metab Clin Exp 1989;38:453-458.
19. Saad M F, Damani S, Gingerich RL et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997;82:579-584.
20. Rebuffé-Scrive M, Anderson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metab Clin Exp 1990;39:1021-1025.
21. Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfützner A. Serum leptin is associated with serum uric acid concentrations in humans. Metab Clin Exp 1999;48:677-680.
22. Ogura T, Matsuura K, Otsuka F et al. Serum leptin correlates with serum uric acid but not serum testosterone in non-obese male adolescents. Res Commun Mol Pathol Pharmacol 2000;107:55-64.
23. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197-216.
24. Thorand B, Baumert J, Döring A et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216-224.